newsfilter
← Latest News
GlobeNewswire·

Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit

PHGE
  • BiomX Inc. (NYSE: PHGE) appointed Prof. Gabby Sarusi as Strategic Advisor on June 02, 2026.
  • Prof. Sarusi will support BiomX's expansion into defense, security, critical infrastructure, & first-response sectors by providing expertise in technology development, operational leadership, & strategic planning.
  • He currently serves as Full Professor & Head of the Photonics & Electro-Optics Department at Ben-Gurion University of the Negev, focusing on infrared detectors, quantum photonic devices, & advanced sensing technologies.
  • Prior to academia, Prof. Sarusi spent 17 years at Elbit Systems Electro-Optics (Elop), holding senior roles including Vice President, Chief Scientist, & Director of Development for advanced thermal imaging systems.
  • His past experience includes leadership in satellite cameras, aerial imaging, hyperspectral observation, & infrared detectors at Elop.
  • Prof. Sarusi has served on the boards of Israel Aerospace Industries, SCD, Opgal, & Medigus, & co-founded companies in AI, augmented reality, nanotechnology, & optical diagnostics.
  • CEO Michael Oster highlighted Prof. Sarusi's 2025 candidacy for the chairmanship of Israel Aerospace Industries as evidence of his credibility within Israel's defense & technology communities.
  • Prof. Sarusi holds dual bachelor's degrees in Nuclear & Materials Engineering from Ben-Gurion University, a master's & Ph.D. in Electrical Engineering from Tel Aviv University, & an Executive MBA from Tel Aviv University's Recanati School of Business.
  • He completed postdoctoral research at AT&T Bell Labs in New Jersey & NASA Jet Propulsion Laboratory in California.
  • BiomX Inc. acquires & develops technologies to identify, track, & counter physical threats, particularly as UAVs & autonomous systems increase in defense & homeland security.
  • The press release includes forward-looking statements regarding BiomX's strategic expansion, portfolio management, & technology deployment capabilities, noting risks such as technical challenges, regulatory changes, & financial qualifications.